Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cefotaxime sodium 500mg powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefotaxime sodium |
Inferred relationship |
Some |
|
Cefotaxime sodium 1g powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefotaxime sodium |
Inferred relationship |
Some |
|
Cefotaxime sodium 10g infusion solution bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefotaxime sodium |
Inferred relationship |
Some |
|
Cefotaxime sodium 2g powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefotaxime sodium |
Inferred relationship |
Some |
|
Cefotaxime sodium 2gm/50mL infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefotaxime sodium |
Inferred relationship |
Some |
|
Cefotaxime sodium 1gm/50mL infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefotaxime sodium |
Inferred relationship |
Some |
|
Cefotaxime (as cefotaxime sodium) 500 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefotaxime sodium |
Inferred relationship |
Some |
|
Product containing precisely cefotaxime (as cefotaxime sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefotaxime sodium |
Inferred relationship |
Some |
|
Cefotaxime sodium 1gm/50mL conventional release solution for infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefotaxime sodium |
Inferred relationship |
Some |
|
Cefotaxime sodium 2gm/50mL conventional release solution for infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefotaxime sodium |
Inferred relationship |
Some |
|
Cefotaxime (as cefotaxime sodium) 500 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefotaxime sodium |
Inferred relationship |
Some |
1 |
Product containing precisely cefotaxime (as cefotaxime sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefotaxime sodium |
Inferred relationship |
Some |
1 |
Cefotaxime (as cefotaxime sodium) 20 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefotaxime sodium |
Inferred relationship |
Some |
1 |
Product containing precisely cefotaxime sodium 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Cefotaxime sodium |
Inferred relationship |
Some |
1 |
Product containing precisely cefotaxime sodium 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Cefotaxime sodium |
Inferred relationship |
Some |
1 |
Product containing precisely cefotaxime sodium 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefotaxime sodium |
Inferred relationship |
Some |
1 |
Product containing precisely cefotaxime sodium 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cefotaxime sodium |
Inferred relationship |
Some |
1 |
Product containing precisely cefotaxime sodium 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cefotaxime sodium |
Inferred relationship |
Some |
1 |
Product containing precisely cefotaxime sodium 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefotaxime sodium |
Inferred relationship |
Some |
1 |
Cefotaxime (as cefotaxime sodium) 2 g powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefotaxime sodium |
Inferred relationship |
Some |
1 |
Product containing precisely cefotaxime (as cefotaxime sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefotaxime sodium |
Inferred relationship |
Some |
1 |
Cefotaxime (as cefotaxime sodium) 1 g powder for solution for infusion and/or injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefotaxime sodium |
Inferred relationship |
Some |
1 |
Product containing precisely cefotaxime (as cefotaxime sodium) 500 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefotaxime sodium |
Inferred relationship |
Some |
1 |
Cefotaxime (as cefotaxime sodium) 2 g powder for solution for infusion and/or injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefotaxime sodium |
Inferred relationship |
Some |
1 |
Cefotaxime (as cefotaxime sodium) 2 g powder for solution for infusion vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cefotaxime sodium |
Inferred relationship |
Some |
1 |